Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: Potential for interaction with brain cannabinoid receptors

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 3, 1996, Pages 207-210

  Boring, D L ^a   Berglund, B A ^b   Howlett, A C ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE);

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; FELIS CATUS;

EID: 0029977961     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90100-3     Document Type: Article

References (18)

1. Lerner R. A., Siuzdak G., Prospero-Garcia O., Henriksen S. J., Boger D. L., Cravatt B. F. Cerebrodiene: A brain lipid isolated from sleep-deprived cats. Proc Natl Acad Sci USA 1994; 91: 9505-9508.
2. Cravatt B. F., Prospero-Garcia O., Siuzdak G. et al. Chemical characterization of a family of brain lipids that induce sleep. Science 1995; 268: 1506-1509.
3. Schmid H. H. O., Schmid P. C., Natarajan V. N-Acylated glycerophospholipids and their derivatives. Prog Lipid Res 1990; 29: 1-43.
4. Mechoulam R., Hanus L., Martin B. R. Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 1994; 48: 1537-1544.
5. DiMarzo V., Fontana A. Anandamide, an endogenous cannabinomimetic eicosanoid: 'Killing two birds with one stone'. Prostaglandins Leukot Essent Fatty Acids 1995; 53: 1-11.
6. Abood M. E., Martin B. R. Neurobiology of marijuana abuse. Trends Pharmacol Sci 1992; 13(5): 201-206.
7. Howlett A. C. Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 1995; 35: 607-634.
8. Shire D., Carillon C., Kaghad M. et al. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 1995; 270: 3726-3731.
9. Abadji V., Lin S., Taha G. et al. (R)-Methanadamide: A chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 1994; 37: 1889-1893.
10. Houston D. B., Evans D. M., Howlett A. C., Melvin L. S. [3H] CP-55,940 binding to the cannabinoid receptor in brain. Biotech Update 1991; 6:21.
11. Lawson W. B., Valenty V. B., Woe J. D., Lobo A. P. Studies on the inhibition of human thrombin: Effects of plasma and plasma constituents. Folia Haematol Leipzig 1982; 109: 52-60.
12. Childers S. R., Sexton T., Roy M. B. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem Pharmacol 1994; 47: 711-715.
13. Pinto J. C., Potie F., Rice K. C. et al. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. Mol Pharmacol 1994; 46: 516-522.
14. Bourne H. R., Sanders D. A., McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991; 349: 117-127.
15. Conklin B. R., Bourne H. R. Structural elements of Ga subunits that interact with Gβτ, receptors, and effectors. Cell 1993; 73: 631-641.
16. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 1993; 231: 313-314.
17. Crawley J. N., Corwin R. L., Robinson J. K., Felder C. C., Devane W. A., Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 1993; 46: 967-972.
18. Smith P. B., Compton D. R., Welch S. P., Razdan R. K., Mechoulam R., Martin B. R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J4 Pharmacol Exp Ther 1994; 270: 219-227.